Published May 4, 2026
| Version 2
Journal article
Open
Efficacy of non-steroidal anti-inflammatory drug (NSAID) treatment for bovine respiratory disease: a systematic review and meta-analysis for the European Network for Optimization of Antimicrobial Therapy guidelines
Authors/Creators
- 1. International Veterinary Evidence-based Guidelines Centre, University of Copenhagen, Fredriksberg C, Denmark
- 2. Veterinary Public Health Institute, University of Bern, Bern, Switzerland
- 3. Department of Internal Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Burdur Province, Turkey
- 4. Scientific directorate of infectious diseases in animals, Sciensano, Brussels, Belgium
- 5. Département des sciences cliniques, University of Montreal Faculty of Veterinary Medicine, Saint-Hyacinthe, Québec, Canada
- 6. Centre for Veterinary Public Health & One Health, University of Veterinary Medicine Vienna, Vienna, Austria
- 7. Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Ås, Norway
- 8. Comparative Biomedical Sciences, The Royal Veterinary College, London, England, UK
- 9. Department of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi, USA
- 10. Norwegian Veterinary Institute, Ås, Norway
- 11. Department of Veterinary and Animal Sciences, University of Copenhagen, Fredriksberg C, Denmark
- 12. UGent Calf Health, Department of Internal Medicine, Reproduction and Population Medicine, Ghent University, Salisburylaan, Belgium
Files
openreseurope-6-25698.pdf
Files
(1.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:3fce09b4ffa88257faccb90364025ad7
|
1.6 MB | Preview Download |
Additional details
References
- Bassetti M, Andreoni M, Santus P (2024). NSAIDs for early management of acute respiratory infections. Curr. Opin. Infect. Dis. doi:10.1097/QCO.0000000000001024
- Behlke EJ, Hannon SJ, Perrett T (2015). Comparative efficacy of ceftiofur crystalline free acid and florfenicol-flunixin meglumine for undifferentiated fever treatment in feedlot calves administered tulathromycin metaphylactically on arrival. Bovine Pract. doi:10.21423/bovine-vol49no1p48-54
- Bednarek D, Zdzisińska B, Kondracki M (2003). Effect of steroidal and non-steroidal anti-inflammatory drugs in combination with long-acting oxytetracycline on non-specific immunity of calves suffering from enzootic bronchopneumonia. Vet. Microbiol. doi:10.1016/S0378-1135(03)00203-7
- Bednarek D, Lutnicki K, Dudek K (2013). The effect of the combined use of a long-acting antimicrobial with NSAID on the clinical status and cellular immune response in calves affected with bovine respiratory disease. Cattle Pract.
- Bokma J, Dewulf J, Deprez P (2018). Risk factors for antimicrobial use in food-producing animals: disease prevention and socio-economic factors as the main drivers?. Vlaams Diergeneeskd Tijdschr.
- Bringhenti L, Pallu M, Silva JC (2021). Effect of treatment of pneumonia and otitis media with tildipirosin or florfenicol + flunixin meglumine on health and upper respiratory tract microbiota of preweaned Holstein dairy heifers. J. Dairy Sci. doi:10.3168/jds.2020-19945
- Damborg P, Allerton F, Bousquet-Mélou A (2024). ENOVAT: the European Network for Optimization of Veterinary Antimicrobial Treatment. Open Res Eur. doi:10.12688/openreseurope.18016.2
- De Koster J, Tena JK, Stegemann MR (2022). Treatment of bovine respiratory disease with a single administration of tulathromycin and ketoprofen. Vet. Rec. doi:10.1002/vetr.834
- Deleforge J, Thomas E, Davot JL (1994). A field evaluation of the efficacy of tolfenamic acid and oxytetracycline in the treatment of bovine respiratory disease. J. Vet. Pharmacol. Ther. doi:10.1111/j.1365-2885.1994.tb00520.x
- Elitok B, Elitok OM (2004). Clinical efficacy of carprofen as an adjunct to the antibacterial treatment of bovine respiratory disease. J. Vet. Pharmacol. Ther. doi:10.1111/j.1365-2885.2004.00589.x
- Ferree LA, Edwards-Callaway LN, Roman-Muniz IN (2023). Oral meloxicam given as an ancillary treatment at respiratory disease diagnosis was not associated with growth, clinical scores, or ultrasound scores in preweaned dairy calves. J. Am. Vet. Med. Assoc. doi:10.2460/javma.23.06.0361
- Francoz D, Buczinski S, Apley M (2012). Evidence related to the use of ancillary drugs in bovine respiratory disease (anti-inflammatory and others): are they justified or not?. Vet. Clin. North Am. Food Anim. Pract. doi:10.1016/j.cvfa.2011.12.003
- Friton GM, Cajal C, Ramirez-Romero R (2005). Long-term effects of meloxicam in the treatment of respiratory disease in fattening cattle. Vet. Rec. doi:10.1136/vr.156.25.809
- Guyatt G, Zhao Y, Mayer M (2023). GRADE guidance 36: updates to GRADE's approach to addressing inconsistency. J. Clin. Epidemiol. doi:10.1016/j.jclinepi.2023.03.003
- Guyatt G, Agoritsas T, Brignardello-Petersen R (2025). Core GRADE 1: overview of the Core GRADE approach. BMJ. doi:10.1136/bmj-2024-081903
- Guzel M, Karakurum MC, Durgut R (2010). Clinical efficacy of diclofenac sodium and flunixin meglumine as adjuncts to antibacterial treatment of respiratory disease of calves. Aust. Vet. J. doi:10.1111/j.1751-0813.2010.00575.x
- Hägglund S, Laloy E, Alvarez I (2024). Effects of early treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on the bronchoalveolar lavage proteome and oxylipids during bovine respiratory syncytial virus (BRSV) infection. PLoS One. doi:10.1371/journal.pone.0309609
- Hannon SJ, Perrett T, Wildman BK (2009). Efficacy of a florfenicol-flunixin meglumine combination product versus tulathromycin or ceftiofur crystalline free acid for the treatment of undifferentiated fever in feedlot calves. Vet. Ther.
- Jim GK, Booker CW, Guichon PT (1999). A comparison of florfenicol and tilmicosin for the treatment of undifferentiated fever in feedlot calves in western Canada. Can. Vet. J.
- Jourquin S, Bokma J, De Cremer L (2022). Randomized field trial comparing the efficacy of florfenicol and oxytetracycline in a natural outbreak of calf pneumonia using lung reaeration as a cure criterion. J. Vet. Intern. Med. doi:10.1111/jvim.16348
- Jourquin S, Lowie T, Debruyne F (2023). Dynamics of subclinical pneumonia in male dairy calves in relation to antimicrobial therapy and production outcomes. J. Dairy Sci. doi:10.3168/jds.2022-22212
- Jourquin S, Debruyne F, Chantillon L (2025a). Noninferiority trial in veal calves on the efficacy of oxytetracycline and florfenicol treatment for pneumonia guided by quick thoracic ultrasound. J. Dairy Sci. doi:10.3168/jds.2024-25172
- Jourquin S, Lowie T, Debruyne F (2025b). Development of a classification system for lung ultrasonographic findings in calves based on the association with cure and production outcomes. J. Dairy Sci. doi:10.3168/jds.2024-25386
- Keita A, Pommier P, Pagot E (2007). A combination oxytetracycline/flunixin treatment of respiratory infections in cattle. Rev Med Vet (Toulouse).
- Kuru T, Lynch JP (1999). Nonresolving or slowly resolving pneumonia. Clin. Chest Med. doi:10.1016/s0272-5231(05)70241-0
- Lockwood PW, Johnson JC, Katz TL (2003). Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease. Vet. Rec. doi:10.1136/vr.152.13.392
- Lowie T, Van Leenen K, Jourquin S (2022). Differences in the association of cough and other clinical signs with ultrasonographic lung consolidation in dairy, veal, and beef calves. J. Dairy Sci. doi:10.3168/jds.2021-21570
- Magnowska Z, Jana B, Brochmann RP (2019). Carprofen-induced depletion of proton motive force reverses TetK-mediated doxycycline resistance in methicillin-resistant Staphylococcus pseudintermedius. Sci. Rep. doi:10.1038/s41598-019-54091-4
- Mahendran SA, Booth R, Bell NJ (2017). Randomised positive control trial of NSAID and antimicrobial treatment for calf fever caused by pneumonia. Vet. Rec. doi:10.1136/vr.104057
- Mahendran SA (2020). Use of fever detection in combination with thoracic ultrasonography to identify respiratory disease, and compare treatments of antimicrobials and NSAID: a randomised study in dairy calves. Vet. Rec. Open. doi:10.1136/vetreco-2020-000415
- Martin MS, Kleinhenz MD, White BJ (2022). Assessment of pain associated with bovine respiratory disease and its mitigation with flunixin meglumine in cattle with induced bacterial pneumonia. J. Anim. Sci. doi:10.1093/jas/skab373
- Moura C, Totton S, Sargeant J (2019). Evidence of improved reporting of swine vaccination trials in the post-REFLECT statement publication period. J. Swine Health Prod. doi:10.54846/jshap/1125
- Nickell J, Bryant L, Lechtenberg KF (2020). Evaluation of antimicrobial or non-antimicrobial treatments in commercial feedlot cattle with mild bovine respiratory disease based on a refined case-definition. Front Vet Sci. doi:10.3389/fvets.2020.571697
- Njoto EN, Chan MF, Bagus Wirayuda AA (2025). Risk factors of nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: a systematic review and meta-analysis of observational studies. Oman Med. J. doi:10.5001/omj.2025.48
- Page MJ, McKenzie JE, Bossuyt PM (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. doi:10.1136/bmj.n71
- Pardon B, Hostens M, Duchateau L (2013). Impact of respiratory disease, diarrhea, otitis and arthritis on mortality and carcass traits in white veal calves. BMC Vet. Res. doi:10.1186/1746-6148-9-79
- Pollreisz JP, Cull C, Lechtenberg K (2022). Comparison of two distinct arrival and treatment programs for bovine respiratory disease in high-risk feeder cattle entering a feedlot. Transl Anim Sci. doi:10.1093/tas/txac102
- Ruh C, Banjade R, Mandadi S (2017). Immunomodulatory effects of antimicrobial drugs. Immunol. Investig. doi:10.1080/08820139.2017.1373900
- Scahill K, Cargnel M, Yildiz R (2026). Efficacy of antimicrobial treatment for bovine respiratory disease: a systematic review and meta-analysis for European Network for Optimization of Veterinary Antimicrobial Therapy guidelines [version 1; peer review: awaiting peer review]. Open Res Eur. doi:10.12688/openreseurope.21879.1
- Scahill K (2026). Supplementary Files to Efficacy of non-steroidal anti-inflammatory drug (NSAID) treatment for bovine respiratory disease: a systematic review and meta-analysis for the European Network for Optimization of Antimicrobial Therapy guidelines. Open Science Framework. doi:10.17605/OSF.IO/8SDMH
- Scott PR (1994). Field study of undifferentiated respiratory disease in housed beef calves. Vet. Rec. doi:10.1136/vr.134.13.325
- Smith RA, Step DL, Woolums AR (2020). Bovine respiratory disease: looking back and looking forward, what do we see?. Vet. Clin. North Am. Food Anim. Pract. doi:10.1016/j.cvfa.2020.03.009
- Sterne JAC, Savović J, Page MJ (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. doi:10.1136/bmj.l4898
- Thiry J, González-Martín JV, Elvira L (2014). Treatment of naturally occurring bovine respiratory disease in juvenile calves with a single administration of a florfenicol plus flunixin meglumine formulation. Vet. Rec. doi:10.1136/vr.102017
- Tomazi ACCH, Tomazi T, Bringhenti L (2023). Treatment with 2 commercial antimicrobials reduced clinical and systemic signs of pneumonia and the abundance of pathogenic bacteria in the upper respiratory tract of preweaning dairy calves. J. Dairy Sci. doi:10.3168/jds.2022-22451
- Van Donkersgoed J, Berg J, Hendrick S (2009). A comparison of florfenicol-flunixin meglumine versus tulathromycin for the treatment of undifferentiated fever in fall-placed feedlot calves. Vet. Ther.
- Van Donkersgoed J, Merrill JK, Hendrick S (2014). Comparative efficacy of tilmicosin, florfenicol, and florfenicol-flunixin meglumine for treatment of undifferentiated fever in backgrounded winter-placed feedlot calves given tilmicosin metaphylactically on arrival. Bovine Pract. doi:10.21423/bovine-vol48no2p103-108
- Voiriot G, Philippot Q, Elabbadi A (2019). Risks related to the use of non-steroidal anti-inflammatory drugs in community-acquired pneumonia in adult and pediatric patients. J. Clin. Med. doi:10.3390/jcm8060786
- Zeng L, Brignardello-Petersen R, Hultcrantz M (2022). GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach. J. Clin. Epidemiol. doi:10.1016/j.jclinepi.2022.07.014